Obesity & Metabolic Health: Panel: Pharmas next frontier @WithTheEconomist
Obesity & Metabolic Health: Panel: Pharmas next frontier @WithTheEconomist
Uploaded June 2026 | Updated September 2026, 2 hours ago
Biotech companies know how to help people lose weight. Now their focus is on new therapies to address side-effects, comorbidities, weight rebound, adherence and efficacy. Which treatments will define the next frontier of obesity and metabolic health medication?
Obesity & Metabolic Health: Panel: Pharmas next frontierFireside chat. Photonics meets quantum: seeing the light on commercial adoptionPanel. Setting the rules of entanglement: building a global standardPanel. Building a scalable space companyPresentation. What next for controlled environment agriculture?Fireside chat. The Central Arctic Ocean at a crossroads: governing before industrialisationQuantum’s missing middle: who is building the connective tissue and enabling infrastructure?Panel. Boards and bots: rewiring leadership for the agentic era1230 Panel harvest now decrypt laterPanel. Sequestering the best outcomes for your carbon creditsInterview. The business case, rewritten: value in the climate transitionFireside chat. Dispelling myths about the roadblocks to commercial fusion
Economist Enterprise – Events |

Obesity & Metabolic Health: Panel: Pharma's next frontier

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER